share_log

Eiger BioPharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner KAWAS LEEN

SEC announcement ·  Oct 30, 2023 16:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more